Novel aflatoxin derivatives and protein conjugates
Christian Cervino1, Dietmar Knopp, Michael G Weller
1Institute of Hydrochemistry, Technische Universität München, Marchioninistrasse 17, 81377 München, Germany. christian.cervino@ch.tum.de
Molecules (Basel, Switzerland)
|September 14, 2007
Summary
This study presents a fast synthesis of novel aflatoxin derivatives and protein conjugates. These compounds are valuable for developing aflatoxin detection methods and generating specific antibodies.
Area of Science:
- Mycotoxicology
- Analytical Chemistry
- Immunochemistry
Background:
- Aflatoxins are toxic and carcinogenic mycotoxins impacting human and animal health.
- Analytical methods require specific aflatoxin derivatives and protein conjugates.
Purpose of the Study:
- To develop a reliable and fast synthesis for novel aflatoxin derivatives.
- To create and characterize aflatoxin-protein conjugates for potential antibody generation.
Main Methods:
- Synthesis of novel aflatoxin derivatives.
- Purification using preparative High-Performance Liquid Chromatography (HPLC).
- Characterization via Electrospray Ionization Mass Spectrometry (ESI-MS) and Nuclear Magnetic Resonance (NMR) spectroscopy.
- Preparation and characterization of aflatoxin-bovine serum albumin conjugates using UV absorption and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-MS).
Main Results:
- Successful synthesis and purification of novel aflatoxin derivatives.
- Characterization confirmed the structure of the new derivatives.
- Novel aflatoxin-bovine serum albumin conjugates were prepared.
- Conjugates were characterized, showing potential as immunogens.
Conclusions:
- The developed methods provide efficient access to novel aflatoxin derivatives and conjugates.
- These compounds are suitable for analytical applications and for raising antibodies with new specificities.
Related Concept Videos
Conjugated Proteins
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

